TE
OLMA icon

Tema ETFs’s Olema Pharmaceuticals OLMA Stock Holding History

Tema ETFs’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998K Buy
79,759
+516
+0.7% +$6.91K 0.03% 291
2026
Q1 		$1.18M Buy
79,243
+34,738
+78% +$773K 0.08% 216
2025
Q4 		$1.11M Buy
+44,505
New +$792K 0.09% 222

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Tema ETFs's OLMA Position: Q2 2026 in Review

Tema ETFs increased its Olema Pharmaceuticals (OLMA) stake by 0.65% in Q2 2026, buying an estimated $6.91K and bringing the position to 79,759 shares worth $998K. The position accounts for 0.03% of the portfolio, ranked #291.

Tema ETFs first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.18M in Q1 2026. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Tema ETFs held 79,759 shares of Olema Pharmaceuticals worth $998K as of Q2 2026.
  • Tema ETFs bought 516 Olema Pharmaceuticals shares in Q2 2026, an estimated $6.91K.
  • Olema Pharmaceuticals made up 0.03% of Tema ETFs's portfolio in Q2 2026, its #291 holding.
  • Tema ETFs first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Tema ETFs's Olema Pharmaceuticals position peaked at $1.18M in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.